Search Results - "Chrysochoou, Elisavet Anna"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Low‐frequency oscillometry indices to assess ventilation inhomogeneity in CF patients by Fouzas, Sotirios, Kogias, Christos, Gioulvanidou, Maria, Bertzouanis, Aris, Chrysochoou, ElisavetAnna, Anthracopoulos, Michael Β., Tsanakas, John, Hatziagorou, Elpis

    Published in Pediatric pulmonology (01-11-2023)
    “…Background The utility of the forced oscillations technique (FOT) in cystic fibrosis (CF) remains uncertain. The aim of this study was to explore the ability…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Toward the Establishment of New Clinical Endpoints for Cystic Fibrosis: The Role of Lung Clearance Index and Cardiopulmonary Exercise Testing by Hatziagorou, Elpis, Kampouras, Asterios, Avramidou, Vasiliki, Toulia, Ilektra, Chrysochoou, Elisavet-Anna, Galogavrou, Maria, Kirvassilis, Fotios, Tsanakas, John

    Published in Frontiers in pediatrics (25-02-2021)
    “…As Cystic Fibrosis (CF) treatment advances, research evidence has highlighted the value and applicability of Lung Clearance Index and Cardiopulmonary Exercise…”
    Get full text
    Journal Article
  4. 4
  5. 5

    A Rare Case of Clavicle Osteomyelitis in a Child and Literature Review by Roilides, Emmanuel, Badekas, Konstantinos, Antachopoulos, Charalampos, Chrysochoou, Elisavet-Anna

    Published in Case reports in pediatrics (01-01-2016)
    “…Acute clavicle osteomyelitis in children is rare representing <3% of osteomyelitis cases. We treated a 12-year-old boy who presented with acute pain in the…”
    Get full text
    Journal Article
  6. 6

    Pulmonary medication adherence among children and adults with cystic fibrosis: Is there an association with disease severity? by Hatziagorou, Elpis, Manika, Katerina, Kyrvasili, Syrmo Styliani, Kotoulas, Serafeim Chrysovalantis, Chrysochoou, Elisavet Anna, Kouroukli, Eleana, Sionidou, Maria, Tsanakas, John

    Published in Pediatric pulmonology (01-12-2022)
    “…Background Adherence to pulmonary medication is pivotal in delaying the progression of lung disease in cystic fibrosis (CF). Further exploring the consequences…”
    Get full text
    Journal Article
  7. 7